Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial
伊诺珠单抗奥佐米星作为单药治疗复发和难治性急性淋巴细胞白血病儿童患者：II 期临床试验结果
期刊:Leukemia
影响因子:12.8
doi:10.1038/s41375-022-01576-3
Edoardo Pennesi #, Naomi Michels #, Erica Brivio, Vincent H J van der Velden, Yilin Jiang, Adriana Thano, Anneke J C Ammerlaan, Judith M Boer, H Berna Beverloo, Barbara Sleight, Ying Chen, Britta Vormoor-Bürger, Susana Rives, Bella Bielorai, Claudia Rössig, Arnaud Petit, Carmelo Rizzari, Gernot Engs
